SCHEMBL474611

SCHEMBL474611

COC(=O)c1ccc(-c2ccccc2)c(C(C)C(O)(c2cc(F)c3c(c2)N(C)C(=O)CO3)C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.35
POLB P06746 1/20 0.35
RORC P51449 3/20 0.33
EGFR P00533 1/20 0.33
PTGS2 P35354 1/20 0.33
MAPK14 Q16539 2/20 0.32
NPC1 O15118 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA3 P34903 1/20 0.32
PDK2 Q15119 1/20 0.31
CASP3 P42574 1/20 0.31
ACLY P53396 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.31
ROCK2 O75116 3/20 0.31
ROCK1 Q13464 3/20 0.31
MALT1 Q9UDY8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474455 0.92 ALDH1A1 (0.34) ALDH1A1MALT1HTR1AHTR1DHTR1B
SCHEMBL474394 0.88 POLB (0.36) SMN1; SMN2POLBEGFRPTGS2MAPK14
SCHEMBL474658 0.86 SMN1; SMN2 (0.36) SMN1; SMN2POLBEGFRPTGS2MAPK14
SCHEMBL474476 0.85 MAPK14 (0.35) SMN1; SMN2POLBEGFRPTGS2MAPK14
SCHEMBL473939 0.80 BDKRB1 (0.41)
SCHEMBL473958 0.80 ALDH1A1 (0.37) POLBKDM4EALDH1A1MALT1
SCHEMBL474400 0.78 BDKRB1 (0.33) PDK2MALT1
SCHEMBL12163873 0.78 BDKRB1 (0.33) PDK2MALT1
SCHEMBL474375 0.78 ALDH1A1 (0.37) ALDH1A1HTR1AHTR1DHTR1B
SCHEMBL474431 0.76 TRPV1 (0.41) POLBCASP3KDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411365-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP disclosed